Covid-19 crisis: 1 in 7 reporting side-effects from Sputnik V, says report

Approximately 14 per cent have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature, said report
New reports to come out of clinical studies have found that 1 in 7 people suffered from side-effects post being inoculated by the Russian vaccine. The Soviet nation's health minister, Mikhail Murashko, in a statement to Moscow Times said that nearly 14 per cent of patients who have been administrated the vaccine reported suffering from side-effects.

However, terming the side-effects to be mild and routine, Murashko still said that the Russian vaccine is still safer and at-par with global competitors.

“Approximately 14 per cent have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,” he said.

Terming these effects to be normal, the minister also said that the symptoms were 'level off' by the next day and they would keep tracking vitals to notice adversities if any.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel